| Total Voting Rights | RNS | 01.03.21 | 15:00:01 |
Voluntary withdrawal Imfinzi US bladder indication 22 February 2021 07:00:08 | RNS | 22.02.21 | 07:00:08 |
Lynparza: IDMC recommend early analysis of OlympiA 17 February 2021 07:00:11 | RNS | 17.02.21 | 07:00:11 |
Filing of Form 20-F with SEC 16 February 2021 11:15:06 | RNS | 16.02.21 | 11:15:06 |
Director/PDMR Shareholding 15 February 2021 15:00:01 | RNS | 15.02.21 | 15:00:01 |
Annual Financial Report 15 February 2021 11:00:02 | RNS | 15.02.21 | 11:00:02 |
AstraZeneca Non-Executive Board changes 11 February 2021 07:01:02 | RNS | 11.02.21 | 07:01:02 |
AZN: full-year 2020 results 11 February 2021 07:00:03 | RNS | 11.02.21 | 07:00:03 |
Divestment of Crestor in Europe completed 10 February 2021 07:00:04 | RNS | 10.02.21 | 07:00:04 |
Update on KESTREL Phase III trial for Imfinzi 05 February 2021 07:00:02 | RNS | 05.02.21 | 07:00:02 |
Forxiga approved in China for heart failure 04 February 2021 07:00:03 | RNS | 04.02.21 | 07:00:03 |
Total Voting Rights 01 February 2021 15:00:00 | RNS | 01.02.21 | 15:00:00 |
AstraZeneca agrees to divest Viela shareholding 01 February 2021 12:15:00 | RNS | 01.02.21 | 12:15:00 |
COVID-19 vaccine authorised for use by the EU 01 February 2021 07:00:09 | RNS | 01.02.21 | 07:00:09 |
| COVID-19 vaccine receives positive opinion in EU | RNS | 29.01.21 | 15:16:39 |
| Block listing application | RNS | 26.01.21 | 15:00:04 |
| Symbicort approved in China for mild asthma | RNS | 26.01.21 | 07:00:04 |
| Calquence approved in Japan for CLL | RNS | 25.01.21 | 07:05:06 |
| Calquence met primary endpoint against ibrutinib | RNS | 25.01.21 | 07:00:07 |
| Enhertu approved in the EU for breast cancer | RNS | 20.01.21 | 07:00:04 |
